Cytovance Biologics' Line of Credit Round

Cytovance Biologics raised a round of funding on October 28, 2014. Investors include Monroe Capital.

Cytovance Biologics is a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentat…

Articles about Cytovance Biologics' Line of Credit Round: